We demonstrate feasibility of using high-density EEG to map a neocortical seizure focus in conjunction with delivery of magnetic therapy. Our patient had refractory seizures affecting the left leg. A five-day course of placebo stimulation followed a month later by active rTMS was directed to the mapped seizure dipole. Active rTMS resulted in reduced EEG spiking, and shortening of seizure duration compared to placebo. Seizure frequency, however, improved similarly in both placebo and active treatment stages. rTMS-evoked EEG potentials demonstrated that a negative peak at 40 ms -believed to represent GABAergic inhibition -was enhanced by stimulation.
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Repetitive Transcranial Magnetic Stimulation Directed to a Seizure Focus Localized by High-Density EEG: a Case Report Introduction Neurostimulation is beneficial against seizures when applied to the left vagus nerve [1] [2] [3] , bilateral anterior nucleus of thalamus [4] or the seizure focus [5] . All of these require surgery. A noninvasive therapeutic neurostimulation method would be of value. Repetitive transcranial magnetic stimulation (rTMS) is one possible therapeutic method, but results of small controlled trials to date have been mixed, with five negative [6] [7] [8] [9] [10] and three positive [11] [12] [13] [14] trials.
Observation of altered seizure counts can require months, so a biomarker of a potentially useful
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A C C E P T E D M A N U S C R I P T therapeutic effect would be useful. EEG evoked potentials in response to the repetitive transcranial magnetic stimulation pulses may be such a marker [15] [16] [17] [18] [19] [20] . The rTMS-evoked EEG potential is multiphasic. Prior studies have suggested that the negative peak at about 40 ms reflects local cortical GABA-A receptor mediated inhibition [21] [22] [23] . Treatments that enhance the N40 peak might therefore be useful candidates for treating seizures.
Commonly employed butterfly (figure-of-eight) rTMS coils deliver local and relatively superficial currents to brain [24] . Therefore, rTMS would be expected to be most effective in treatment of superficial, well-localized seizure foci. This issue was explored in one study [9] utilizing a combination of MRI, video-EEG, FDG-PET, and SISCOM SPECT to localize seizure foci, but results were negative. In the present case report, we demonstrate the feasibility of targeting rTMS to a seizure focus localized by inverse dipole methods using high-density EEG.
Methods
Institutional approval: The protocol was approved by the Stanford IRB, and conducted under the FDA's investigator device exemption (IDE) G150216-A001 held by Electrical Geodesic, Inc.
The subject met the safety exclusion criteria of Rossi and Hallett [25] : no hearing problems or ringing in ears; not pregnant; no metal in the brain or skull (except for dental fillings); no cochlear implants; no implanted neurostimulator, except that the seizure /loss of consciousness criteria were not used as exclusions, since the subject did have epilepsy.
Study Design: This was a single-blind prospective placebo-controlled, n-of-one study. After a baseline period, placebo stimulation was done over for 5 consecutive days and then active
stimulation was performed for 5 consecutive days beginning a month later. The subject kept a daily log of seizure frequency, severity and duration. The subject was blinded as to treatment arm, but the investigators were not. Ancillary measures included stimulation tolerability, neuropsychological measures, EEG spikes, inter-channel EEG connectivity and rTMS-evoked EEG potentials. The goal was to show feasibility for a larger double-blinded study.
Head Modeling: Head modeling was performed according to the protocol of Electrical Geodesics, Inc. (EGI) [26, 27] . A high-quality MRI was performed with T1 sequences showing good grey-white matter discrimination and imaging to below the jaw. A photogrammetry system [28] took pictures of electrode placements on the scalp via the 256-contact Gel-cap (EGI®) [29] .
Each electrode was labeled and registered to the MRI. Images were imported into the Osirix® environment [30, 31] . Tailairach landmarks were chosen to correspond to the anterior and posterior commissures in the midline. Each MRI slice was then reviewed to verify by visual inspection and edited to remove artifactual or obviously inaccurate portrays of the cortical folds.
The software then created a 4800-voxel head model, which could be displayed on the Repetitive transcranial magnetic stimulation: rTMS was delivered with an STM9000 stimulator (EBNeuro SpA® , Firenze, Italy) with a 70 mm air-cooled flat butterfly coil delivering biphasic waveforms. The maximum machine output is approximately 3.2 Tesla. EMG skin electrodes were placed over the right first dorsal interosseous muscle to determine resting motor threshold (RMT), defined as the minimal stimulation intensity able to produce a visible twitch in at least 5 of 10 trials [32] . RMT was determined once at the start of the experiment for each subject. The coil was placed tangentially to be as close to the scalp as possible without touching, positioned at a 45° angle to the midline, with the handle aimed posteriorly [33] . Coil position and orientation were monitored by a Galileo NT system (EB Neuro SpA, Firenze, Italy), coupled with a Polaris Vicra infrared camera (NDI, Waterloo, Canada). This permitted repeated targeting of the interictal spike focus. Earplugs protected hearing [34] and reduced auditory evoked potential artifacts.
Each of the five consecutive (Mon-Fri) daily sessions required about 1 hour of EEG setup and 2 hours of stimulation, including two 10-minute breaks per session. The first 5-daily sessions used a placebo coil (EBNeuro™, butterfly cooled placebo coil 70mm, Model E2108, setting the same as for active stimulation) that generated scalp sensations, but with a coil configuration that cancelled the majority of deeper stimulation to brain. The subject was unaware of which session was placebo and which was active therapy. A second run of 5 daily stimulation sessions occurred
at least a month after the placebo run, using an active stimulation coil. To record baseline TEPs, 50 pulses were delivered at 110% of motor threshold at a frequency of 1 pulse every 3 seconds before delivery of rTMS. This was repeated after delivery of rTMS.
For our patient, rTMS was targeted to the best dipole fit to generate his distribution of scalp EEG potentials during interictal spikes. This was concordant with the right brain parasagittal motor cortex area for the left leg. Individual stimuli above motor threshold could variably evoke left leg twitches, sometimes coupled with less vigorous right leg twitches.
Stimulation was delivered as three 500-pulse blocks at 1 Hz, separated by 10-min breaks for a total of 1500 pulses. Stimulation intensity was set to 90% of motor threshold. Hand EMG was monitored with a Physio16 input box (Electrical Geodesics Incorporated, Eugene, USA) at 1 kHz sampling, and occasionally indicated when the incrementing current was close to producing finger movement. EMG also provided a quantitative way to correlate EEG changes with evoked motor changes.
TEP analysis: rTMS-evoked EEG potentials were processed offline using MATLAB (Mathworks®). The 50 test pulses before and after rTMS were averaged to form pre-rTMS and post-rTMS datasets. rTMS artifacts were eliminated by a 20-ms spline interpolation from 10 ms before to 10 ms after rTMS. After interpolation, EEG signals were high-pass filtered above 1 Hz.
Pulses were epoched from 300 ms before the pulse to 500 ms after. Because rTMS produced a large DC shift, baselines were corrected with respect to the TMS-free pre-stimulation interval from 300 to 50 ms prior to the stimuli. Independent component analysis was performed on epochs to separate electrical artifacts from physiological response to TMS pulse. [70] [71] [72] [73] [74] [75] Components with muscle activity, eye blinks and residual of TMS artifacts were removed.
Finally, the average of epochs was computed for further analyses.
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Connectivity analysis:
Connectivity analysis was performed offline using the TRENTOOL3 Open-Source MATLAB toolbox for transfer entropy estimation [35] in MATLAB (Mathworks®). Transfer entropy estimation can be considered an extension of Granger causality [36] with greater tolerance for nonlinear relations and outliers. Predictive information transfer was calculated from 15 minutes of resting state data from each treatment condition (pre-rTMS, post-placebo, and post-rTMS) between the electrode directly beneath the site of rTMS stimulation as described above ("the target electrode"), and electrodes F4, C4, P4, O2, F3, C3, P3, O1, Fp2, F8, T8 (T4), P8 (T6), Fp1, F7, T7 (T3), P7 (T5), Fz, and Pz per the international 10-20 electrode system.
Prediction time was set to 100 ms, the optimization method utilized the Ragwitz criterion for choosing modeling parameters in TRENTOOL3, and the nearest neighbor method of estimation was used. Surrogate data for statistical analysis was created using the "block reverse" method within TRENTOOL3. The Faes method [37] was utilized to minimize volume conduction effects. Statistical significance was calculated using a 2-tailed independent samples t-Test looking for transfer entropy (condition) > transfer entropy (shifted data). Correction for multiple comparisons was achieved by using the False Discovery Rate method [38] .
Results
Case Report
The subject was a 56- 
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Results:
Baseline testing: Figure 1 shows a 3T MRI taken prior to rTMS treatment. The left hippocampus is atrophied and with indistinct architecture.
FIGURE 1 NEAR HERE
His high-density EEG and corresponding inverse solution to the source dipole is portrayed in Figure 2 . In the baseline recording, the most frequent (n=42) spikes group was averaged, demonstrating a sharp wave with phase reversals over the right superior frontalparietal regions. An inverse dipole model of generating dipoles using the LAURA algorithm [39] with data from all 256 channels localized an extracellularly negative current dipole over the right Brodman area 3 on the postcentral parietal gyrus. 
FIGURE 3 NEAR HERE
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Connectivity Analysis: Connectivity analysis demonstrated no significant predictive information transfer between the target electrode and electrodes F4, C4, P4, O2, F3, C3, P3, O1, Fp2, F8, T8 (T4), P8 (T6), Fp1, F7, T7 (T3), P7 (T5), Fz, or Pz in any of the conditions with correction for multiple comparisons (data not shown). When correction for multiple comparisons was not performed (Figure 4A, 4B) , both the pre-rTMS and post-placebo conditions demonstrated predictive information transfer from electrode F4 to the target electrode (p = 0.0129 and p = 0.0131 respectively), and the post-placebo condition also showed predictive information transfer from electrode P4 (p = 0.0202). Without correction for multiple comparisons, the post-rTMS condition ( Figure 4C ) demonstrated predictive information transfer from electrode C4 to the target electrode (p = 0.0028).
FIGURE 4 NEAR HERE
Neuropsychology: Neuropsychological test results before and after a course of stimulation are listed in Table 1 . Learning of a 9-item word list did not differ before and after treatment with rTMS, but short and long-delay recall scores declined following rTMS. Recognition discrimination for the list items versus distractor items did not differ. The subject had significantly less perseverative responses, a measure of executive functioning, following rTMS.
There were no significant differences between the subject's quality of life ratings preand post-rTMS.
*CVLT II indicates California Verbal Learning Test. Significant differences between pre-and post-test scores [40] . **WCST indicates Wisconsin Card Sorting Test. Significant difference between pre-and post-test scores [41] . QOLIE indicates Quality of Life in Epilepsy. No significant changes [42] . Spike and Seizure Counts:
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Each EEG was recorded for 2 hours. The first baseline EEG contained 66 interictal spikes or sharp waves, the second baseline 71, the post-placebo study 16 and the post-active rTMS study 0 spikes. Seizure information is shown in Table 2 and the plot of total daily seizure counts in Figure 5 .
The mean number of seizures per day was 2.36 ± 1.07 (mean ± standard deviation) in the baseline phase, 1.62 ± 1.10 after placebo stimulation and 1.64 ± 1.01 after active rTMS. Despite a reduction of seizures compared to baseline (p<0.001), there was no significant difference in counts after placebo versus active stimulation (p=0.92). Figure 4 shows a plot of daily seizure frequencies over time.
The subject, blinded as to placebo vs. active stimulation, keep a log of seizure severity (1 for mild, 2 for medium, 3 for strong) and duration (1 for short, 2 for normal, 3 for long). Both measures improved markedly (p<= 0.001) from baseline to either placebo or active stimulation.
Seizure severity was less, but not significantly, in baseline versus placebo (p=0.215). Seizure duration was significantly shorter in the active treatment stage (p=0.016). 
FIGURE 5 NEAR HERE
Discussion:
This case report demonstrates proof-in-principle of delivering rTMS to a seizure focus via high-density EEG targeted to the spike dipole demonstrated by the inverse dipole algorithm.
Placebo stimulation can be used effectively in subjects with epilepsy. The EEG potentials evoked by repetitive transcranial magnetic stimulation can be recorded [15, [17] [18] [19] [20] [43] [44] [45] [46] and displayed after suitable signal processing, as has been described by many others [47] [48] [49] . Our patient showed an increase in the N40 potential after a course of rTMS. This component of the rTMS evoked EEG potential is believed to reflect fast GABAergic inhibition in cortex [21] [22] [23] , and therefore an increase might signal enhanced inhibition, potentially useful in limiting seizures. It is also possible to record changes in inter-channel EEG connectivity after stimulation, as has previously been reported [44, 50, 51] . Encoding of new information was not hindered as recognition performance was similar across the two time periods. In a systematic review of cognitive effects of low-frequency rTMS that included normal controls, as well as individuals with mood disorders, stroke, and other organic syndromes, one study [35] reported decline in verbal fluency and verbal retrieval. Only one study of rTMS [13] included patients with epilepsy and no declines were noted on any measure, but instead suggested improvement.
This study was not designed or powered to demonstrate efficacy, in that spike and seizure counts were not blinded, and the order of placebo and active therapy was not randomized; thus, we cannot rule out non-specific time/recovery effects. The single-blind placebo was key in demonstrating superiority of rTMS for post-treatment versus baseline seizure counts, but not for placebo versus active treatment, emphasizing the importance of placebo controls in clinical trials of rTMS. Spike frequency improved to zero in a single post-treatment record, but this is not significant in a single case.
The mean and standard deviation data obtained in this subject can be used to make a very rough sample size calculation for a future larger study. Assuming that a 25% reduction is A C C E P T E D M A N U S C R I P T clinically significant and using the baseline seizure frequency and square root of the variance, alpha error of 0.05 and beta error of 0.2, the number needed in each group would be 94 subjects [52] . A 33% reduction would require 53 subjects in each group and a criterion of 50% reduction would require 23 per group.
These findings may be helpful in design of a prospective, randomized trial of rTMS for epilepsy by targeting the stimulation to the spike dipole revealed by high-density EEG recordings.
Conclusions
Some studies suggest that repetitive transcranial magnetic stimulation (rTMS) can 
Figure Legends
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A  This case report may assist with development of a larger controlled study.
